Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Human Genome Epidemiology Literature Finder|Home|PHGKB

Human Genome Epidemiology Literature Finder


Last data update: Jan 25, 2025. (Total: 235671Documents)
   dataset        GWAS Only
Filtered By:

Previous    

Records 1 - 10 (of 10 Records)

Query Trace: Neoplasms and BPI[original query]
Do CYP2D6 genotypes reflect oxycodone requirements for cancer patients treated for cancer pain? A cross-sectional multicentre study.
European journal of clinical pharmacology 2012 Jan 68 (1): 55-64.
Andreassen Trine Naalsund, Eftedal Ingrid, Klepstad Pål, Davies Andrew, Bjordal Kristin, Lundström Staffan, Kaasa Stein, Dale O
Innate immunity gene polymorphisms and the risk of colorectal neoplasia.
Carcinogenesis 2013 Nov 34 (11): 2512-20.
Chang Cindy M, Chia Victoria M, Gunter Marc J, Zanetti Krista A, Ryan Bríd M, Goodman Julie E, Harris Curtis C, Weissfeld Joel, Huang Wen-Yi, Chanock Stephen, Yeager Meredith, Hayes Richard B, Berndt Sonja I,
Next-generation sequencing reveals mutational accordance between cell-free DNA from plasma, malignant pleural effusion and ascites and directs targeted therapy in a gastric cancer patient.
Cancer biology & therapy 2018 8 20 (1): 15-20.
Zhou Shujuan, Xu Bo, Qi Liang, Zhu Dongqin, Liu Baorui, Wei J
Dual therapy with dolutegravir plus boosted protease inhibitor as maintenance or salvage therapy in highly experienced people living with HIV.
International journal of antimicrobial agents 2021 7 58 (3): 106403.
Lee Yu-Lin, Lin Kuan-Yin, Cheng Shu-Hsing, Lu Po-Liang, Wang Ning-Chi, Ho Mao-Wang, Yang Chia-Jui, Liou Bo-Huang, Tang Hung-Jen, Huang Shie-Shian, Huang Sung-Hsi, Chen Tun-Chieh, Lin Chi-Ying, Lin Shih-Ping, Lee Yuan-Ti, Hung Chien-Ching,
Safety, pharmacokinetics, and efficacy of BPI-15086 in patients with EGFR T790M-mutated advanced non-small-cell lung cancer: results from a phase I, single-arm, multicenter study.
ESMO open 2022 5 7 (3): 100473.
Xing P, Zheng X, Wang Y, Chu T, Wang S, Jiang J, Qian J, Han X, Ding L, Wang Y, Cui L, Li H, Li L, Chen X, Han B, Hu P, Shi
Safety, Efficacy, and Pharmacokinetics of Rezivertinib (BPI-7711) in Patients With Advanced NSCLC With EGFR T790M Mutation: A Phase 1 Dose-Escalation and Dose-Expansion Study.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2022 Feb .
Shi Yuankai, Zhao Yanqiu, Yang Sheng, Zhou Jianying, Zhang Liangming, Chen Gongyan, Fang Jian, Zhu Bo, Li Xingya, Shu Yongqian, Shi Jianhua, Zheng Rongsheng, Wang Donglin, Yu Huiqing, Huang Jianan, Zhuang Zhixiang, Wu Gang, Zhang Longzhen, Guo Zhongliang, Greco Michael, Li Xiao, Zhang
Safety, efficacy and pharmacokinetics of BPI-9016M in c-MET overexpression or MET exon 14 skipping mutation patients with locally advanced or metastatic non-small-cell lung cancer: a phase Ib study.
BMC cancer 2023 4 23 (1): 331.
Hu Xingsheng, Cui Xinge, Wang Ziping, Liu Yunpeng, Luo Ying, Zhong Wei, Zhao Hui, Yao Mengxing, Jiang Da, Wang Mingxia, Chen Minjiang, Zheng Xin, Ding Lieming, Wang Yang, Yuan Xiaobin, Wu Pengxiang, Hu Bei, Han Xiaohong, Shi Yuank
Results of the phase IIa study to evaluate the efficacy and safety of rezivertinib (BPI-7711) for the first-line treatment of locally advanced or metastatic/recurrent NSCLC patients with EGFR mutation from a phase I/IIa study.
BMC medicine 2023 1 21 (1): 11.
Shi Yuankai, Zhou Jianying, Zhao Yanqiu, Zhu Bo, Zhang Liangming, Li Xingya, Fang Jian, Shi Jianhua, Zhuang Zhixiang, Yang Sheng, Wang Donglin, Yu Huiqing, Zhang Longzhen, Zheng Rongsheng, Greco Michael, Wang Tingti
Development and validation of a deep learning-based model to predict response and survival of T790M mutant non-small cell lung cancer patients in early clinical phase trials using electronic medical record and pharmacokinetic data.
Translational lung cancer research 2024 5 13 (4): 706-720.
Ning Lou, Xinge Cui, Xinyuan Lin, Ruyun Gao, Chi Xu, Nan Qiao, Ji Jiang, Lu Wang, Weicong Wang, Shanbo Wang, Wei Shen, Xin Zheng, Xiaohong H
A novel clinical brain prognostic index for KRAS-mutated lung cancer and brain metastases (KRAS-BPI): Real-world evidence from two large European centers.
Lung cancer (Amsterdam, Netherlands) 2024 12 199 108065.
Ioannis Zerdes, Caroline Kamali, Berglind Johannsdottir, Miriam Blasi, Christin Assmann, Daniel Kazdal, Albrecht Stenzinger, Marcus Skribek, Simon Ekman, Petros Christopoulos, Georgios Tsakon
TOP